Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Corporate Presentations
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Corporate Presentations
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
9-Nov-2022
Kazia presents to Bell Potter Healthcare Conference
14-Sep-2022
Kazia presentation to HCW Bioconnect
23-Jun-2022
Kazia presentation on paxalisib for childhood brain cancer
13-Jun-2022
Kazia Therapeutics welcomes presentation of positive paxalisib data at international symposium
19-Jan-2022
Kazia Corporate Deck
1
